SCHEMBL32688295

SCHEMBL32688295

Cc1c(-c2cccc(C3CC3)c2)c(C#N)c(SCc2nnn[nH]2)[nH]c1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CXCR2 P25025 3/20 0.36
▸ RAPGEF4 Q8WZA2 6/20 0.34
▸ HSD11B1 P28845 3/20 0.34
▸ CTSS P25774 1/20 0.34
▸ CTSK P43235 1/20 0.34
▸ NOTUM Q6P988 1/20 0.33
▸ CHRM5 P08912 1/20 0.33
▸ CX3CR1 P49238 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ GFER P55789 1/20 0.33
▸ APLNR P35414 1/20 0.32
▸ BRD4 O60885 1/20 0.32
▸ NPC1 O15118 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ PKM P14618 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32687972 0.90 HSD11B1 (0.38) CXCR2HSD11B1CTSSCTSKNOTUM
SCHEMBL32688173 0.89 HSD11B1 (0.38) CXCR2HSD11B1CTSSCTSKNOTUM
SCHEMBL32688428 0.88 CXCR2 (0.38) CXCR2RAPGEF4HSD11B1NOTUMCHRM5
SCHEMBL32688106 0.87 ALDH1A1 (0.38) CXCR2KDM4EALDH1A1LMNAMAPT
SCHEMBL32688401 0.87 POLB (0.37) CXCR2HSD11B1KDM4ETSHRGFER
SCHEMBL32688132 0.84 CXCR2 (0.36) CXCR2RAPGEF4HSD11B1CTSSCTSK
SCHEMBL32688125 0.78 ACMSD (0.37) HSD11B1KDM4ENPC1ALDH1A1LMNA
SCHEMBL32688370 0.78 POLB (0.41) CXCR2HSD11B1BRD4ALDH1A1MEN1
SCHEMBL32688035 0.77 MEN1 (0.41) CXCR2HSD11B1BRD4MEN1POLB
SCHEMBL26404304 0.76 HSD11B1 (0.34) CXCR2HSD11B1KDM4ETSHRGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK CXCR2 2082/4885RAPGEF4 4386/4885HSD11B1 61/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback